gms | German Medical Science

26. Jahrestagung der Deutschen Retinologischen Gesellschaft

Deutsche Gesellschaft für Retinologie

27.09.2013, Hamburg

II. Genes and the retina – what matters?

Meeting Abstract (13rg10)

Next-generation sequencing: A new era in research and diagnostics of retinal dystrophies

Bolz HJ
Meeting Abstract (13rg11)

Retinal dystrophies – fundamental aspects of gene therapy

Leroy BP
Meeting Abstract (13rg12)

Methods in Genetics in inherited retinal disorders and Gene therapy trials

Zeitz C, Shamieh SE, Audo I, Sahel JA
Meeting Abstract (13rg13)

Evaluation of the effects of ranibizumab (Lucentis®) therapy on the macular function in patients with wet age-related macular degeneration using multifocal-electroretinogram and microperimetry

Reinsberg M, Hilgers RD, Lüke J, Nassar K, Grisanti S, Lüdeke I, Lüke M
Meeting Abstract (13rg14)

Standardized analysis of morphological OCT parameters and correlation with best-corrected visual acuity (BCVA) in antiangiogenic therapy of neovascular age-related macular degeneration (AMD)

Simader C, Waldstein S, Kundi M, Schmidt-Erfurth U
Meeting Abstract (13rg15)

Choroidal neovascularisation (CNV) during anti-VEGF therapy: Changes in microperimetric visual field defects are similar to changes in optical coherence tomography (OCT) findings in most cases

Inhoffen W, Hagemann U, Feucht M, Aisenbrey S, Bartz-Schmidt KU
Meeting Abstract (13rg16)

Identification of clinically relevant OCT parameters over two years of treatment in neovascular AMD

Schmidt-Erfurth U, Waldstein S, Kundi M, Simader C
Meeting Abstract (13rg17)

Treatment of wAMD patients with VEGF inhibitors: Insights from the routine clinical practice in Germany – the PONS Study

Agostini H, Mueller S, Ehlken C, Bauer-Steinhusen U, Hasanbasic Z, Wilke T
Meeting Abstract (13rg18)

The potential of the anti VEGF drugs cannot be used under real life conditions in Germany: Results from a 4 year follow up of 77 patients

Schrader WF, Bernhard A, Dietz C, Sommer K, Panidou E
Meeting Abstract (13rg19)

“Real-Life”-Data on Treatment of Diabetic Macular Oedema with Ranibizumab: Effect on Visual Acuity, OCT Development and the Number of Retinal Microaneurysms

Gerding H, Hefner L, Timmermann M